Dynamics of patents, orphan drug designation, licensing, and revenues from drugs for rare diseases: The market expansion of eculizumab.

Dynamics of patents, orphan drug designation, licensing, and revenues from drugs for rare diseases: The market expansion of eculizumab.

<h4>Background</h4>This study examines the dynamics of the eculizumab patenting, orphan designation, and marketing authorization process in different countries and regulatory systems and analyzes drug revenues since its first marketing authorization.<h4>Methods</h4>A retrospe...

Full description

Bibliographic Details
Main Authors: Rosângela Caetano, Marilena Cordeiro Dias Villela Correa, Pedro Villardi, Paulo Henrique Almeida Rodrigues, Claudia Garcia Serpa Osorio-de-Castro
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2021-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0247853

Internet

https://doi.org/10.1371/journal.pone.0247853

Similar Items